Background risk should be taken into account when reporting vaccine effectiveness
Am J Transplant
.
2022 Jul;22(7):1927-1928.
doi: 10.1111/ajt.16961.
Epub 2022 Jan 24.
Authors
Ivan Zahradka
1
,
Vojtech Petr
1
,
Maria Magicova
1
,
Ondrej Viklicky
1
Affiliation
1
Department of Nephrology, Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
PMID:
35043536
DOI:
10.1111/ajt.16961
No abstract available
Publication types
Letter
Comment
MeSH terms
Adverse Drug Reaction Reporting Systems*
Vaccination
Vaccine Efficacy*